Seasoned financial executive Peter M. Carlson has been hired as chief financial officer of Dallas-based Spectral AI Inc., an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care.
Carlson will succeed Nils Windler, who will remain with Spectral AI to work closely with Carlson, support an orderly transition of responsibilities, and provide financial accounting support to the company.
“As the new CFO of Spectral AI, Pete brings an exceptional track record as a senior financial executive at several public companies in multiple industries, including two Fortune 50 entities, and most recently at a healthcare company focused on chronic and hard-to-heal wounds. A highly qualified and a respected leader, Pete has made a difference by leading critical strategic partnerships, driving significant creative financial transactions, and leveraging deep relationships in the capital markets,” Spectral AI CEO Wensheng Fan said in a statement. “As Spectral AI embarks on introducing its innovative technologies to the market, Pete’s extensive expertise will be invaluable as we navigate the complexities of the financial landscape and strategic opportunities, while propelling the Company to new heights.”
Focusing on investors and capital providers
Most recently, Carlson was CFO at MiMedx Group, Inc., a pioneer and leader in the advanced wound care space. Prior to his work at MiMedx, Carlson served as chief operating officer at Brighthouse Financial, Inc., and played an essential role in establishing Brighthouse as a separate public company after its spin-off from MetLife Inc., where he worked for eight years.
At MetLife, as chief accounting officer, Carlson led accounting, tax and financial reporting activities, along with budgeting and financial planning. Prior to MetLife, he was the controller at Wachovia Corp. and an audit partner for a Big Four accounting firm. Carlson serves as a board member at White Mountains Insurance Group and as a trustee for Wake Forest University.
“I am excited to work with Wensheng and the team at Spectral AI, which has game-changing healthcare technology in the acute and chronic wound care space that I anticipate will improve the quality of patient care and reduce costs in the overall healthcare system. The growth and value potential for Spectral AI are significant,” Carlson said in a statement. “My focus will be on informing investors and capital providers about the business opportunities made possible by the breakthrough technology the team developed.”
Tech for better wound care
Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers.
The company said it is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention.
With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, the company said that DeepView is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.